EUVIMEDEUVIMED entdecken
Crossref

Monitoring Direct Thrombin Inhibitors With Calibrated Diluted Thrombin Time vs Activated Partial Thromboplastin Time in Pediatric Patients

Rida A Hasan iD, Jennifer Pak, Christa Jefferis Kirk, Joshua M Friedland-Little, Wayne L Chandler

American Journal of Clinical Pathology · 2023

DOI: 10.1093/ajcp/aqac131 ↗

Kurz gefasst

Fachartikel in der Zeitschrift American Journal of Clinical Pathology, 2023. Verfasst von Rida A Hasan und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Laboratory Medicine and Pathology, University of Washington, Seattle, WA, USA. Hauptthemen laut MEDLINE: Antithrombins, Pipecolic Acids. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 41 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

Activated partial thromboplastin time (aPTT) is the primary test used to monitor intravenous (IV) direct thrombin inhibitors (DTIs) but has many limitations. The plasma diluted thrombin time (dTT) has shown better correlation with DTI levels than aPTT. This study compared dose-response curves for dTT and aPTT in pediatric patients receiving argatroban and bivalirudin.

Methods

A retrospective review of pediatric patients treated with argatroban (n = 45) or bivalirudin (n = 14) monitored with dTT and aPTT.

Results

The dTT assay was calibrated to report DTI concentrations in µg/mL for argatroban and bivalirudin with good analytic sensitivity and specificity. The dTT was fivefold more likely to show a stable dose-response slope than the aPTT (P < .0002; odds ratio, 4.9). For patients in whom both dTT and aPTT showed a significant correlation between dose and assay results, dTT had a higher average correlation factor compared with aPTT (P = .007). Argatroban dose-response slopes showed more inter- and intrapatient variation than bivalirudin (dose-response slope coefficient of variation, 132% vs 52%).

Conclusions

The dTT assay was more likely to show a stable dose response and have a stronger correlation with DTI dose than aPTT. Argatroban shows more variation in dose response than bivalirudin.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AntithrombinsPipecolic AcidsHumansChildPartial Thromboplastin TimeThrombin TimeBlood Coagulation TestsHirudinsAnticoagulantsThrombinRecombinant ProteinsArginineSulfonamides

Stichwörter der Autor:innen

ArgatrobanBivalirudinDirect thrombin inhibitorDrug monitoringThrombin time

Substanzen

AntithrombinsPipecolic AcidsHirudinsAnticoagulantsThrombinRecombinant ProteinsargatrobanArginineSulfonamides

Autor:innen und Institutionen

  • Department of Laboratory Medicine and Pathology, University of Washington, Seattle, WA, USA.
  • Division of Pediatric Hematology/Oncology, Department of Pediatrics.
  • Department of Pharmacy.
  • Divison of Pediatric Cardiology, Department of Pediatrics.
  • Department of Laboratories, Seattle Children's Hospital, Seattle, WA, USA.

ORCID-Profile: Rida A Hasan

Zitieren

APA

Hasan, R. A., Pak, J., Kirk, C. J., Friedland-Little, J. M., & Chandler, W. L. (2023). Monitoring Direct Thrombin Inhibitors With Calibrated Diluted Thrombin Time vs Activated Partial Thromboplastin Time in Pediatric Patients. American Journal of Clinical Pathology. https://doi.org/10.1093/ajcp/aqac131

Vancouver

Hasan RA, Pak J, Kirk CJ, Friedland-Little JM, Chandler WL. Monitoring Direct Thrombin Inhibitors With Calibrated Diluted Thrombin Time vs Activated Partial Thromboplastin Time in Pediatric Patients. American Journal of Clinical Pathology. 2023. doi:10.1093/ajcp/aqac131

BibTeX
@article{Hasan2023,
  author = {Hasan, Rida A and Pak, Jennifer and Kirk, Christa Jefferis and Friedland-Little, Joshua M and Chandler, Wayne L},
  title = {Monitoring Direct Thrombin Inhibitors With Calibrated Diluted Thrombin Time vs Activated Partial Thromboplastin Time in Pediatric Patients},
  journal = {American Journal of Clinical Pathology},
  year = {2023},
  doi = {10.1093/ajcp/aqac131}
}
Kostenlos starten →